Skip to main content
. 2022 Oct 6;12:910871. doi: 10.3389/fonc.2022.910871

Table 2.

Immunosuppressive regimen and histopathological findings.

No. Group Immuno-suppression Cortico-steroids Others Chemotherapygiven pT G Pn V N R Lymph nodes at SL Lymph Nodes at LT Lymph Nodes positive
1 LT-Gem tacrolimus yes MMF yes pT2 G2 Pn0 V0 N0 R0 5 12 0
2 LT alone tacrolimus yes MMF no pT2 G1 Pn1 V0 N0 R0 3 11 0
3 LT alone tacrolimus yes MMF no pT2 G3 Pn0 V0 N0 R0 5 9 0
4 LT alone cyclosporin A yes MMF no pT2 G2 Pn1 V0 N1 R0 1 8 1
5 LT-Gem tacrolimus yes MMF yes pT2 G2 Pn1 V0 N0 R0 3 8 0
6 LT-Gem tacrolimus yes none yes pT2 G2 Pn1 V0 N1 R0 3 6 3

No., Patient number; LT-Gem, liver transplantation and adjuvant gemcitabine (intervention group); LT alone, liver transplantation alone (control group); MMF, mycophenolate mofetil; SL, staging laparotomy; LT, liver transplantation.